AI assistant
Health Catalyst, Inc. — Director's Dealing 2021
Jan 21, 2021
33681_dirs_2021-01-20_e31f597b-73ae-4fef-a8ca-18a22b367bac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-01-15
Reporting Person: Pramoda Anita (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-15 | Common Stock | M | 1247.00 | $10.66 | Acquired | 6690.00 | Direct |
| 2021-01-15 | Common Stock | M | 7500.00 | $10.66 | Acquired | 14190.00 | Direct |
| 2021-01-15 | Common Stock | M | 8753.00 | $10.66 | Acquired | 22943.00 | Direct |
| 2021-01-15 | Common Stock | M | 16500.00 | $10.40 | Acquired | 39443.00 | Direct |
| 2021-01-15 | Common Stock | S | 8753.00 | $48.0465 | Disposed | 30690.00 | Direct |
| 2021-01-15 | Common Stock | S | 1247.00 | $48.00 | Disposed | 29443.00 | Direct |
| 2021-01-15 | Common Stock | S | 7500.00 | $48.0425 | Disposed | 21943.00 | Direct |
| 2021-01-15 | Common Stock | S | 16500.00 | $48.0897 | Disposed | 5443.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-15 | Stock Option (Right to Buy) | $10.66 | M | 7500.00 | Disposed | 2027-04-27 | Common Stock (7500.00) | Direct |
| 2021-01-15 | Stock Option (Right to Buy) | $10.66 | M | 8753.00 | Disposed | 2027-04-27 | Common Stock (8753.00) | Direct |
| 2021-01-15 | Stock Option (Right to Buy) | $10.66 | M | 1247.00 | Disposed | 2027-04-27 | Common Stock (1247.00) | Direct |
| 2021-01-15 | Stock Option (Right to Buy) | $10.40 | M | 16500.00 | Disposed | 2026-04-28 | Common Stock (16500.00) | Direct |
Footnotes
F1: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 14, 2019, in accordance with Rule 10b5-1.
F2: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $48.00 to $48.21, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 - 4.
F3: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $48.00 to $48.18, inclusive.
F4: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $48.00 to $48.28, inclusive.
F5: 25% of the 20,000 shares underlying the options vested in an annual installment on April 27, 2018 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on April 27, 2021.
F6: 25% of the 62,500 shares underlying the options vested in an annual installment on April 28, 2017 and the remaining balance vested in equal monthly installments until the option vested in full on April 28, 2020.